Showing results (161-170 of 185) with videos related to

Sort By:
Pageof 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1993
Effective therapy for poor-prognosis non-Hodgkin's lymphoma with 8 weeks of high-dose-intensity combination chemotherapyT M Waits, F A Greco, J P Greer, et al.
Seminars in Oncology|June 1, 1987
High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: an updateS N Wolff, R H Herzig, G L Phillips, et al.
The American Journal of Medicine|April 1, 1988
Re-treatment of aplastic anemia with antithymocyte globulin or antilymphocyte serumR T Means, S B Krantz, E N Dessypris, et al.
Leukemia|October 14, 2014
Immunosuppressive therapy of LGL leukemia: prospective multicenter phase II study by the Eastern Cooperative Oncology Group (E5998)T P Loughran, L Zickl, T L Olson, et al.
Annals of Internal Medicine|November 1, 1986
Non-Hodgkin's lymphoma after treatment of Hodgkin's disease: association with Epstein-Barr virusA F List, J P Greer, J B Cousar, et al.
Cancer|January 1, 1989
Peripheral T-cell lymphomaJ O Armitage, J P Greer, A M Levine, et al.
Leukemia|October 18, 2012
Naive T-cells in myelodysplastic syndrome display intrinsic human telomerase reverse transcriptase (hTERT) deficiencyL Yang, A Mailloux, D E Rollison, et al.
Annals of Internal Medicine|June 15, 1993
High-dose weekly intravenous immunoglobulin to prevent infections in patients undergoing autologous bone marrow transplantation or severe myelosuppressive therapy. A study of the American Bone Marrow Transplant GroupS N Wolff, J W Fay, R H Herzig, et al.
Bone Marrow Transplantation|September 6, 2001
Valacyclovir for the prevention of cytomegalovirus infection after allogeneic stem cell transplantation: a single institution retrospective cohort analysisM Vusirikala, S N Wolff, R S Stein, et al.
Leukemia & Lymphoma|November 8, 2001
Age and cytogenetics as predictors of event free survival in patients with acute non-lymphocytic leukemia receiving high dose cytosine arabinoside and daunorubicin as consolidation chemotherapyR S Stein, S N Wolff, J P Greer, et al.
Pageof 19